Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
1,668,034
-
Share change
-
-288,977
-
Total reported value
-
$11,835,200
-
Put/Call ratio
-
30%
-
Price per share
-
$7.10
-
Number of holders
-
24
-
Value change
-
-$1,795,596
-
Number of buys
-
12
-
Number of sells
-
11
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q4 2017
As of 31 Dec 2017,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
24 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,668,034 shares.
The largest 10 holders included
Knoll Capital Management, LP, MACQUARIE GROUP LTD, First Eagle Investment Management, LLC, EDMOND DE ROTHSCHILD HOLDING S.A., RAYMOND JAMES & ASSOCIATES, ARK Investment Management LLC, GROUP ONE TRADING, L.P., ALPS ADVISORS INC, LADENBURG THALMANN FINANCIAL SERVICES INC., and Zurcher Kantonalbank (Zurich Cantonalbank).
This page lists
24
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.